WATCHMAN & WATCHMAN FLX®
Left Atrial Appendage Closure Implant
The first in the state to perform the WATCHMAN Left Atrial Appendage Closure Implant and since then, we’ve completed over 400 successful procedures.
Our team of experts are procedural leaders who regularly use novel devices in the treatment of AFib such as the WATCHMAN® and WATCHMAN FLX® Left Atrial Appendage Closure Implant.
About WATCHMAN
For patients with AFib who are at risk for stroke but are unsuitable for blood thinners, the WATCHMAN and WATCHMAN FLX® Left Atrial Appendage Closure implants are an alternative to reduce their risk of AFib-related stroke.
The WATCHMAN and WATCHMAN FLX® Left Atrial Appendage Closure Implant next generation technology is a one-time, minimally invasive procedure designed to help treat more patients safely and effectively to ensure the best long-term outcomes. A relatively new and innovative treatment for patients with non-valvular atrial fibrillation, the WATCHMAN technology is the only treatment for patients who previously did not have an option to reduce the risk of stroke in atrial fibrillation.
The device closes off an area of the heart called the left atrial appendage (LAA) to keep harmful blood clots from forming in the LAA and potentially causing a stroke. By closing off the LAA, the risk of stroke is reduced and, over time, patients stop taking blood-thinning medication.
The WATCHMAN technology has been implanted in more than 100,000 patients worldwide and is done in a one-time procedure. It’s a permanent device that doesn’t have to be replaced and can’t be seen outside the body.
When you have AFib, choose West Virginia’s most trusted and proven leader.